Company Filing History:
3 out of 21 
2 out of 33 
2 out of 1,345 
Years Active: 2020-2025
Title: Inventor Spotlight: Kyle Havens
Introduction:
Kyle Havens, a renowned inventor hailing from Seattle, WA, has made significant contributions to the field of genome editing with a total of 5 patents under his name. His innovative work has revolutionized the prevention and treatment of various health conditions, ranging from hypercholesterolemia to cancer.
Latest Patents:
Havens' most recent patents include groundbreaking inventions such as PCSK9 endonuclease variants and CBLB endonuclease variants. The former focuses on editing the PCSK9 gene to address hypercholesterolemia and related conditions, while the latter targets the CBLB gene for combating cancer, infectious diseases, autoimmune diseases, inflammatory diseases, and immunodeficiencies.
Career Highlights:
Having showcased his expertise in companies like 2seventy Bio, Inc. and Bluebird Bio, Inc., Kyle Havens has garnered recognition for his exceptional work in the biotechnology sector. His patents stand as a testament to his dedication to advancing genome editing technologies for the betterment of healthcare.
Collaborations:
Throughout his career, Kyle Havens has collaborated with talented individuals such as Jordan Jarjour and Anne-Rachel Krostag. Notably, Anne-Rachel Krostag has been a key collaborator, bringing a unique perspective and contributing significantly to their shared projects. Her expertise as a woman in the field adds diversity and depth to their innovative endeavors.
Conclusion:
In conclusion, Kyle Havens' contributions to the field of genome editing have paved the way for novel treatments and therapies across various health conditions. His inventive spirit, coupled with collaborative efforts with talented peers like Anne-Rachel Krostag, continues to drive innovation in the biotechnology industry. Kyle Havens stands as a beacon of inspiration for aspiring inventors looking to make a lasting impact on the world of healthcare innovation.